271 related articles for article (PubMed ID: 12576312)
1. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans.
Li Z; Ajdic J; Eigenthaler M; Du X
Blood; 2003 Jun; 101(11):4423-9. PubMed ID: 12576312
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide.
Jensen BO; Selheim F; Døskeland SO; Gear AR; Holmsen H
Blood; 2004 Nov; 104(9):2775-82. PubMed ID: 15265792
[TBL] [Abstract][Full Text] [Related]
3. Regulation of VASP serine 157 phosphorylation in human neutrophils after stimulation by a chemoattractant.
Eckert RE; Jones SL
J Leukoc Biol; 2007 Nov; 82(5):1311-21. PubMed ID: 17684042
[TBL] [Abstract][Full Text] [Related]
4. KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells.
Burkhardt M; Glazova M; Gambaryan S; Vollkommer T; Butt E; Bader B; Heermeier K; Lincoln TM; Walter U; Palmetshofer A
J Biol Chem; 2000 Oct; 275(43):33536-41. PubMed ID: 10922374
[TBL] [Abstract][Full Text] [Related]
5. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
[TBL] [Abstract][Full Text] [Related]
6. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
Eigenthaler M; Nolte C; Halbrügge M; Walter U
Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets.
Sudo T; Ito H; Kimura Y
Platelets; 2003 Sep; 14(6):381-90. PubMed ID: 14602552
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide/cyclic GMP signaling.
Ibarra-Alvarado C; Galle J; Melichar VO; Mameghani A; Schmidt HH
Mol Pharmacol; 2002 Feb; 61(2):312-9. PubMed ID: 11809855
[TBL] [Abstract][Full Text] [Related]
9. Association of VASP with TRPC4 in PKG-mediated inhibition of the store-operated calcium response in mesangial cells.
Wang X; Pluznick JL; Settles DC; Sansom SC
Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1768-76. PubMed ID: 17913834
[TBL] [Abstract][Full Text] [Related]
10. Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G.
Deguchi A; Soh JW; Li H; Pamukcu R; Thompson WJ; Weinstein IB
Mol Cancer Ther; 2002 Aug; 1(10):803-9. PubMed ID: 12492113
[TBL] [Abstract][Full Text] [Related]
11. Antimitogenic actions of organic nitrates are potentiated by sildenafil and mediated via activation of protein kinase A.
Osinski MT; Rauch BH; Schrör K
Mol Pharmacol; 2001 May; 59(5):1044-50. PubMed ID: 11306686
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent inhibitory effects of cGMP-analogues on thrombin-induced platelet-derived microparticles formation, platelet aggregation, and P-selectin expression.
Nygaard G; Herfindal L; Kopperud R; Aragay AM; Holmsen H; Døskeland SO; Kleppe R; Selheim F
Biochem Biophys Res Commun; 2014 Jul; 449(3):357-63. PubMed ID: 24845383
[TBL] [Abstract][Full Text] [Related]
13. cGMP-dependent protein kinase in regulation of basal tone and in nitroglycerin- and nitric-oxide-induced relaxation in porcine coronary artery.
Qin X; Zheng X; Qi H; Dou D; Raj JU; Gao Y
Pflugers Arch; 2007 Sep; 454(6):913-23. PubMed ID: 17377806
[TBL] [Abstract][Full Text] [Related]
14. Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein.
Russo I; Del Mese P; Doronzo G; De Salve A; Secchi M; Trovati M; Anfossi G
Clin Chem; 2007 Jun; 53(6):1053-60. PubMed ID: 17463178
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet effects of caffeic acid due to Ca(2+) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ
J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646
[TBL] [Abstract][Full Text] [Related]
16. The vasodilator-stimulated phosphoprotein is regulated by cyclic GMP-dependent protein kinase during neutrophil spreading.
Lawrence DW; Pryzwansky KB
J Immunol; 2001 May; 166(9):5550-6. PubMed ID: 11313394
[TBL] [Abstract][Full Text] [Related]
17. Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein.
Sabetkar M; Naseem KM; Tullett JM; Friebe A; Koesling D; Bruckdorfer KR
Nitric Oxide; 2001 Jun; 5(3):233-42. PubMed ID: 11384196
[TBL] [Abstract][Full Text] [Related]
18. Vasodilator-Stimulated Phosphoprotein (VASP)-dependent and -independent pathways regulate thrombin-induced activation of Rap1b in platelets.
Benz PM; Laban H; Zink J; Günther L; Walter U; Gambaryan S; Dib K
Cell Commun Signal; 2016 Sep; 14(1):21. PubMed ID: 27620165
[TBL] [Abstract][Full Text] [Related]
19. cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets.
Makhoul S; Trabold K; Gambaryan S; Tenzer S; Pillitteri D; Walter U; Jurk K
Cell Commun Signal; 2019 Sep; 17(1):122. PubMed ID: 31519182
[TBL] [Abstract][Full Text] [Related]
20. Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway.
Russo I; Del Mese P; Viretto M; Doronzo G; Mattiello L; Trovati M; Anfossi G
Clin Biochem; 2008 Mar; 41(4-5):343-9. PubMed ID: 18022387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]